|
FY2026
12 months to Jan 31, 2026
|
FY2025
12 months to Jan 31, 2025
|
FY2024
12 months to Jan 31, 2024
|
FY2023
12 months to Jan 31, 2023
|
FY2022
12 months to Jan 31, 2022
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expenses | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Debt extinguishment loss | |||||
| Interest income | |||||
| Interest expense | |||||
| Change in fair value of warrant liabilities | |||||
| Other income (expense), net | |||||
| Total other income (expense), net | |||||
| Total loss before income taxes | |||||
| Provision for income taxes | |||||
| Net loss | |||||
| Foreign currency translation adjustment, net of tax | |||||
| Comprehensive loss | |||||
| Basic net loss per share attributable to common stockholders (in USD per share) | |||||
| Diluted net loss per share attributable to common stockholders (in USD per share) | |||||
| Basic weighted-average common shares outstanding used in computing net loss per share attributable to common stockholders (in shares) | |||||
| Diluted weighted-average common shares outstanding used in computing net loss per share attributable to common stockholders (in shares) |
Loading...
